Security key
22663K107
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX)
CUSIP: 22663K107
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 105,000,216
- Total 13F shares
- 15,234,699
- Share change
- -3,697,168
- Total reported value
- $229,128,583
- Price per share
- $15.04
- Number of holders
- 60
- Value change
- -$94,271,503
- Number of buys
- 24
- Number of sells
- 24
Report period
Q3 2019
Institutions
60
Top holders
10
CRNX full security history
Newer quarter: Q4 2019
Previous quarter: Q2 2019
Crinetics Pharmaceuticals, Inc. SEC filings
Crinetics Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 22663K107
Recent filing periods:
Top shareholders of CRNX - Crinetics Pharmaceuticals, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.4%
|
3,620,701
|
$90,518,000 | — | 30 Jun 2019 | |
| Vivo Capital, LLC |
13F
|
Company |
3.2%
|
3,375,169
|
$84,379,000 | — | 30 Jun 2019 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.5%
|
2,587,953
|
$64,698,000 | — | 30 Jun 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.9%
|
2,039,282
|
$50,982,000 | — | 30 Jun 2019 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.8%
|
1,875,209
|
$46,880,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.89%
|
932,424
|
$23,312,000 | — | 30 Jun 2019 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.77%
|
803,839
|
$20,096,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.48%
|
504,539
|
$12,614,000 | — | 30 Jun 2019 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.48%
|
499,542
|
$12,489,000 | — | 30 Jun 2019 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.47%
|
490,000
|
$12,250,000 | — | 30 Jun 2019 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.46%
|
487,916
|
$12,198,000 | — | 30 Jun 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.19%
|
203,628
|
$5,091,000 | — | 30 Jun 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.17%
|
180,990
|
$4,525,000 | — | 30 Jun 2019 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.16%
|
167,700
|
$4,193,000 | — | 30 Jun 2019 | |
| Novo Holdings A/S |
13F
|
Company |
0.13%
|
135,009
|
$3,375,000 | — | 30 Jun 2019 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.13%
|
132,985
|
$3,325,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.11%
|
119,535
|
$2,988,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.1%
|
107,744
|
$2,694,000 | — | 30 Jun 2019 | |
| Polar Capital LLP |
13F
|
Company |
0.1%
|
100,000
|
$2,500,000 | — | 30 Jun 2019 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.07%
|
73,925
|
$1,848,000 | — | 30 Jun 2019 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.07%
|
69,670
|
$1,742,000 | — | 30 Jun 2019 | |
| ALPS ADVISORS INC |
13F
|
Company |
0.05%
|
50,525
|
$1,263,000 | — | 30 Jun 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
46,146
|
$1,154,000 | — | 30 Jun 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
38,586
|
$964,000 | — | 30 Jun 2019 | |
| Opaleye Management Inc. |
13F
|
Company |
0.03%
|
36,000
|
$900,000 | — | 30 Jun 2019 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.03%
|
34,238
|
$857,000 | — | 30 Jun 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
29,706
|
$742,000 | — | 30 Jun 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
20,199
|
$505,000 | — | 30 Jun 2019 | |
| Swiss National Bank |
13F
|
Company |
0.02%
|
17,900
|
$448,000 | — | 30 Jun 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
17,000
|
$425,000 | — | 30 Jun 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.01%
|
12,751
|
$319,000 | — | 30 Jun 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
12,700
|
$318,000 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
12,613
|
$316,000 | — | 30 Jun 2019 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.01%
|
11,793
|
$295,000 | — | 30 Jun 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.01%
|
9,700
|
$242,000 | — | 30 Jun 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
9,000
|
$225,000 | — | 30 Jun 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
8,633
|
$216,000 | — | 30 Jun 2019 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.01%
|
8,419
|
$210,000 | — | 30 Jun 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
7,022
|
$176,000 | — | 30 Jun 2019 | |
| HERSHEY TRUST CO |
13F
|
Company |
0.01%
|
6,753
|
$169,000 | — | 30 Jun 2019 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.01%
|
5,862
|
$146,548 | — | 30 Jun 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,643
|
$92,000 | — | 30 Jun 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
3,278
|
$81,000 | — | 30 Jun 2019 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
3,161
|
$79,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3,033
|
$75,000 | — | 30 Jun 2019 | |
| Jacobi Capital Management LLC |
13F
|
Company |
0%
|
3,000
|
$75,000 | — | 30 Jun 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
1,843
|
$46,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1,289
|
$32,000 | — | 30 Jun 2019 | |
| TIVERTON ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
1,208
|
$30,000 | — | 30 Jun 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
1,022
|
$25,550 | — | 30 Jun 2019 |
Institutional Holders of Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) as of Q3 2019
As of 30 Sep 2019,
Crinetics Pharmaceuticals, Inc. - COMMON STOCK (CRNX) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
15,234,699 shares.
The largest 10 holders included
FMR LLC, PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, JANUS HENDERSON GROUP PLC, VICTORY CAPITAL MANAGEMENT INC, and Opaleye Management Inc..
This page lists
60
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
Q2 2019 holders
63
Q3 2019 holders
60
Holder diff
-3
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.